{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:13:38Z","timestamp":1787026418910,"version":"build-2736575974"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Primary hyperparathyroidism (PHPT) is a common endocrine disorder of calcium metabolism. However, data concerning a large cohort of PHPT patients in the Chinese population are scarce. Thus, the objective of this study was to determine the general clinical signatures of 457 Chinese PHPT patients and explore the clinical characteristic differences between benign and malignant PHPT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A single-center retrospective study was designed. Medical records between preoperation and postoperative follow-up, were assessed and statistical analysis of the clinical data was performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Patients with PHPT aged 12\u201387 years, with a mean onset age of 56.16 \u00b1 14.60 years, were included. Most patients (68.7%) in our center had symptomatic patterns described as bone pain (74.8%), urolithiasis (25.5%), fatigue (17.5%), and pathological fracture (13.1%), but an increasing tendency has been established in the proportion of patients with asymptomatic forms. Correlation analysis revealed that patients with higher serum levels of parathyroid hormone (PTH) and calcium presented higher serum levels of bone turnover markers (BTMs) and lower 25-hydroxy-vitamin D (25OHD) values (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt;0.001). Gains in bone mineral density (BMD) at L1\u20134, the femoral neck and the total hip were observed 1\u20132 years after parathyroidectomy (9.6, 5.9, and 6.8%). Parathyroid carcinoma patients presented prominently higher serum PTH and calcium levels and BTMs and lower BMD at femoral neck and total hip than benign PHPT patients (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt;0.05), while no significant differences in age, sex, and serum 25OHD concentration were observed between benign and malignant PHPT patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PHPT should be paid attention to in the patients with bone pain. While, BMD and BTMs can differentiate parathyroid carcinoma from parathyroid adenoma and hyperplasia to some extent. In addition, anti-osteoporosis drugs could be used when necessary to avoid hip fractures in patients with parathyroid carcinoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2021.602221","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T04:00:26Z","timestamp":1614225626000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Clinical Characteristics of Primary Hyperparathyroidism: 15-Year Experience of 457 Patients in a Single Center in China"],"prefix":"10.3389","volume":"12","author":[{"given":"Xiaoyun","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youben","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03520.x","article-title":"Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK","volume":"71","author":"Yu","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10354-013-0235-z","article-title":"Clinical aspects of primary hyperparathyroidism: clinical manifestations, diagnosis, and therapy","volume":"163","author":"Gasser","year":"2013","journal-title":"Wien Med Wochenschr"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"Yeh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1210\/jc.2018-01225","article-title":"Primary Hyperparathyroidism","volume":"103","author":"Bilezikian","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.104","article-title":"Primary hyperparathyroidism","volume":"14","author":"Walker","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-017-0833-8","article-title":"Primary hyperparathyroidism: insights from the Indian PHPT registry","volume":"36","author":"Bhadada","year":"2018","journal-title":"J Bone Miner Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/952426","article-title":"Primary hyperparathyroidism: 11-year experience in a single institute in Thailand","volume":"2012","author":"Prasarttong-Osoth","year":"2012","journal-title":"Int J Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-018-0922-3","article-title":"The characteristics of clinical changes in primary hyperparathyroidism in Chinese patients","volume":"37","author":"Yao","year":"2019","journal-title":"J Bone Miner Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(17)31430-7","article-title":"Hyperparathyroidism","volume":"391","author":"Bilezikian","year":"2018","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102012","article-title":"Parathyroid cancer: An update","volume":"86","author":"Rodrigo","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2914","article-title":"The changing clinical patterns of primary hyperparathyroidism in Chinese patients: data from 2000 to 2010 in a single clinical center","volume":"98","author":"Zhao","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-017-4322-7","article-title":"Characteristics, management, and outcome of primary hyperparathyroidism at a single clinical center from 2005 to 2016","volume":"29","author":"Sun","year":"2018","journal-title":"Osteoporos Int"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3881\/j.issn.1000-503X.2011.03.023","article-title":"Clinical symptoms in 455 hyperparathyroidism patients","volume":"33","author":"Dong","year":"2011","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"B14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/cen.13055","article-title":"Preoperative diagnosis and prognosis in 40 Parathyroid Carcinoma Patients","volume":"85","author":"Xue","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B15","article-title":"Primary hyperparathyroidism in women: a tale of two cities\u2013New York and Beijing","volume":"45","author":"Bilezikian","year":"2000","journal-title":"Int J Fertil Womens Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2011.08.001","article-title":"Correlation between tumor measurement on Computed Tomography and resected specimen size in lung adenocarcinomas","volume":"75","author":"Lampen-Sachar","year":"2012","journal-title":"Lung Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.3390\/cancers11111676","article-title":"Parathyroid Cancer: A Review","volume":"11","author":"Machado","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/513925","article-title":"Establishing reference intervals for bone turnover markers in the healthy shanghai population and the relationship with bone mineral density in postmenopausal women","volume":"2013","author":"Hu","year":"2013","journal-title":"Int J Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1001\/archsurg.139.1.77","article-title":"Surgical treatment for primary hyperparathyroidism in Hong Kong: changes in clinical pattern over 3 decades","volume":"139","author":"Lo","year":"2004","journal-title":"Arch Surg"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1714213","article-title":"Primary Hyperparathyroidism","volume":"379","author":"Insogna","year":"2018","journal-title":"N Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ecl.2016.09.012","article-title":"Primary Hyperparathyroidism: Effects on Bone Health","volume":"46","author":"Zanocco","year":"2017","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1415","article-title":"Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Silverberg","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.07s202","article-title":"Vitamin D deficiency and primary hyperparathyroidism","author":"Silverberg","year":"2007","journal-title":"J Bone Mineral Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/bf03344140","article-title":"A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism","volume":"29","author":"Boudou","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2005.02371.x","article-title":"Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism","volume":"63","author":"Moosgaard","year":"2005","journal-title":"Clin Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcot.2019.07.004","article-title":"Vitamin D for skeletal and non-skeletal health: What we should know","volume":"10","author":"Charoenngam","year":"2019","journal-title":"J Clin Orthop Trauma"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2022","article-title":"Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation","volume":"100","author":"Walker","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1417","article-title":"Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism","volume":"99","author":"Marcocci","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.7044","article-title":"Effect of parathyroidectomy for primary hyperparathyroidism on bone mineral density in postmenopausal women","volume":"97","author":"Sitges-Serra","year":"2010","journal-title":"Br J Surg"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1215","article-title":"The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years","volume":"93","author":"Rubin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-014-2555-6","article-title":"Predictors of bone mineral density improvement in patients undergoing parathyroidectomy for primary hyperparathyroidism","volume":"38","author":"Sharma","year":"2014","journal-title":"World J Surg"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.308.6924.343b","article-title":"Mortality and morbidity after hip fractures","volume":"308","author":"Beringer","year":"1994","journal-title":"BMJ"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/jso.20182","article-title":"Parathyroid carcinoma","volume":"89","author":"Mittendorf","year":"2005","journal-title":"J Surg Oncol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000491039","article-title":"Parathyroid Carcinoma","volume":"51","author":"Cetani","year":"2019","journal-title":"Front Horm Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-015-4672-3","article-title":"Parathyroid Carcinoma: An Update on Treatment Outcomes and Prognostic Factors from the National Cancer Data Base (NCDB)","volume":"22","author":"Asare","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1590\/2359-3997000000224","article-title":"Evaluation of preoperative ultrasonographic and biochemical features of patients with aggressive parathyroid disease: is there a reliable predictive marker","volume":"60","author":"Cakir","year":"2016","journal-title":"Arch Endocrinol Metab"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2012.27.8.890","article-title":"Preoperative predictive factors for parathyroid carcinoma in patients with primary hyperparathyroidism","volume":"27","author":"Bae","year":"2012","journal-title":"J Korean Med Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-019-02069-7","article-title":"Ultrasound combined with biochemical parameters can predict parathyroid carcinoma in patients with primary hyperparathyroidism","volume":"66","author":"Liu","year":"2019","journal-title":"Endocrine"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.602221\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T04:00:29Z","timestamp":1614225629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.602221\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,25]]},"references-count":39,"alternative-id":["10.3389\/fendo.2021.602221"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.602221","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,25]]},"article-number":"602221"}}